BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37043902)

  • 1. Human pegivirus viremia in HCV/HIV co-infected patients: Direct acting antivirals exert anti-pegivirus effects.
    Hlavay BA; Zhuo R; Ogando N; Charlton C; Stapleton JT; Klein MB; Power C
    J Clin Virol; 2023 May; 162():105445. PubMed ID: 37043902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-Dependent RNA Polymerase of the Second Human Pegivirus Exhibits a High-Fidelity Feature.
    Chen S; Wu J; Yang X; Sun Q; Liu S; Rashid F; Dzakah EE; Wang H; Wang J; Gong P; Tang S
    Microbiol Spectr; 2022 Oct; 10(5):e0272922. PubMed ID: 35980196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-free therapy with direct acting antivirals for HCV/HIV-1 co-infected Japanese patients with inherited bleeding disorders.
    Uemura H; Tsukada K; Mizushima D; Aoki T; Watanabe K; Kinai E; Teruya K; Gatanaga H; Kikuchi Y; Sugiyama M; Mizokami M; Oka S
    PLoS One; 2017; 12(10):e0186255. PubMed ID: 29045448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-genome sequencing of human Pegivirus variant from an Egyptian patient co-infected with hepatitis C virus: a case report.
    Soliman HK; Abouelhoda M; El Rouby MN; Ahmed OS; Esmat G; Hassan ZK; Hafez MM; Mehaney DA; Selvaraju M; Darwish RK; Osman YA; Zekri AN
    Virol J; 2019 Nov; 16(1):132. PubMed ID: 31711510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Human Pegivirus, HPgV-2 (HHpgV-1), Is Tightly Associated With Hepatitis C Virus (HCV) Infection and HCV/Human Immunodeficiency Virus Type 1 Coinfection.
    Wang H; Wan Z; Xu R; Guan Y; Zhu N; Li J; Xie Z; Lu A; Zhang F; Fu Y; Tang S
    Clin Infect Dis; 2018 Jan; 66(1):29-35. PubMed ID: 29020289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difference of Intrahost Dynamics of the Second Human Pegivirus and Hepatitis C Virus in HPgV-2/HCV-Coinfected Patients.
    Liang Y; Hu F; Fan H; Li L; Wan Z; Wang H; Shui J; Zhou Y; Tong Y; Cai W; Tang S
    Front Cell Infect Microbiol; 2021; 11():728415. PubMed ID: 34466405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY).
    Wilson E; Covert E; Hoffmann J; Comstock E; Emmanuel B; Tang L; Husson J; Chua J; Price A; Mathur P; Rosenthal E; Kattakuzhy S; Masur H; Kottilil S
    J Hepatol; 2019 Sep; 71(3):498-504. PubMed ID: 31173815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral therapy for HCV in hemophilia A patients with HIV-1 co-infection.
    Xiao H; Chen J; Wang J; Li J; Yang F; Lu H
    Medicine (Baltimore); 2019 Jul; 98(30):e16524. PubMed ID: 31348267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rates of hepatitis C virus (HCV) cure using direct-acting antivirals in HIV/HCV-coinfected patients: a real-world perspective.
    Hawkins C; Grant J; Ammerman LR; Palella F; Mclaughlin M; Green R; Mcgregor D; Stosor V
    J Antimicrob Chemother; 2016 Sep; 71(9):2642-5. PubMed ID: 27330060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy.
    Milazzo L; Lai A; Calvi E; Ronzi P; Micheli V; Binda F; Ridolfo AL; Gervasoni C; Galli M; Antinori S; Sollima S
    HIV Med; 2017 Apr; 18(4):284-291. PubMed ID: 27477612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C and Human Pegivirus Coinfection in Patients with Chronic Hepatitis C from the Brazilian Amazon Region: Prevalence, Genotypes and Clinical Data.
    Nunes PF; da Cruz Coelho E; da Silva JR; da Silva Costa CC; Sampaio RMA; Frade PCR; Ponteira NA; da Cruz SS; Seabra AD; Carneiro DM; Burbano RMR; Martins LC
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European Study.
    Amele S; Peters L; Rodger A; Lundgren J; Rockstroh J; Matulionyte R; Leen C; Jabłonowska E; Østergaard L; Bhagani S; Sarcletti M; Clarke A; Falconer K; Wandeler G; Domingo P; Maltez F; Zaccarelli M; Chkhartisvili N; Szlavik J; Stephan C; Fonquernie L; Aho I; Mocroft A;
    J Acquir Immune Defic Syndr; 2021 Feb; 86(2):248-257. PubMed ID: 33079903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the second human pegivirus (HPgV-2) is primarily a lymphotropic virus and can replicate independent of HCV replication.
    Wan Z; Liu J; Hu F; Shui J; Li L; Wang H; Tang X; Hu C; Liang Y; Zhou Y; Cai W; Tang S
    Emerg Microbes Infect; 2020; 9(1):485-495. PubMed ID: 32100631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-existing, treatment-specific resistance-associated substitutions in hepatitis C virus genotype 1 and 3 and viral RNA titers during treatment with direct-acting antivirals.
    Sølund C; Pedersen MS; Fahnøe U; Filskov J; Jenssen H; Weis N; Schønning K; Bukh J
    APMIS; 2023 Aug; 131(8):426-433. PubMed ID: 37355962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.
    Fabbri G; Mastrorosa I; Vergori A; Mazzotta V; Pinnetti C; Grisetti S; Zaccarelli M; Ammassari A; Antinori A
    BMC Infect Dis; 2017 Mar; 17(1):182. PubMed ID: 28249574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human pegivirus (HPgV, GBV-C) RNA in volunteer blood donors from a public hemotherapy service in Northern Brazil.
    Silva ASN; Silva CP; Barata RR; da Silva PVR; Monteiro PDJ; Lamarão L; Burbano RMR; Nunes MRT; de Lima PDL
    Virol J; 2020 Oct; 17(1):153. PubMed ID: 33054824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections.
    Sun HY; Cheng CY; Lin CY; Yang CJ; Lee NY; Liou BH; Tang HJ; Liu YM; Lee CY; Chen TC; Huang YC; Lee YT; Tsai MJ; Lu PL; Tsai HC; Wang NC; Hung TC; Cheng SH; Hung CC
    World J Gastroenterol; 2022 Mar; 28(11):1172-1183. PubMed ID: 35431505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between HIV and Human Pegivirus (HPgV) Load in Co-Infected Patients: Insights from Prevalence and Genotype Analysis.
    Köksal MO; Pirkl M; Sarsar K; Ilktaç M; Horemheb-Rubio G; Yaman M; Meşe S; Eraksoy H; Akgül B; Ağaçfidan A
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38275941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
    Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
    World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection.
    Berg MG; Lee D; Coller K; Frankel M; Aronsohn A; Cheng K; Forberg K; Marcinkus M; Naccache SN; Dawson G; Brennan C; Jensen DM; Hackett J; Chiu CY
    PLoS Pathog; 2015 Dec; 11(12):e1005325. PubMed ID: 26658760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.